Joshua Levine - Accuray Incorporated CEO and President and Director
| ARAY Stock | USD 2.02 0.04 1.94% |
CEO
Mr. Joshua H. Levine is a President, Chief Executive Officer, Director of Accuray Inc., since October 12, 2012. He was the President, Chief Executive Officer, and a director of two other publicly traded global medical device firms, including Mentor Corporationrationration, a surgical implantmedical device manufacturer in the aesthetics space from 2004 to 2009, and, prior to joining Accuray, with Immucor Corporationrationration, a diagnostics manufacturer of automated instrumentation and reagents used in blood transfusion procedures. Mr. Levine currently serves on the Board of Directors of Natus Medical Incorporated, a provider of medical devices, software services for the newborn care, neurology, sleep, hearing and balance markets since 2012.
| Age | 66 |
| Tenure | 13 years |
| Phone | 608 824 2800 |
| Web | https://www.accuray.com |
Accuray Incorporated Management Efficiency
Accuray Incorporated's management efficiency ratios could be used to measure how well Accuray Incorporated manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | CEO Age | ||
| Gary Maharaj | SurModics | 62 | |
| Joseph Burnett | Clearpoint Neuro | 48 | |
| Joseph Woody | Avanos Medical | 58 | |
| Charles II | Apyx Medical | 59 | |
| Massimo Calafiore | Orthofix Medical | 53 | |
| David Mowry | Cutera Inc | 62 | |
| Karen Zaderej | Axogen Inc | 63 | |
| Michael CPA | Avanos Medical | 52 | |
| Taylor Harris | Cutera Inc | 49 | |
| Albert DaCosta | Paragon 28 | 52 | |
| Robert Claypoole | Bioventus | 52 | |
| Joel Becker | Neuropace | 57 | |
| Mark Throdahl | Orthopediatrics Corp | 74 | |
Management Performance
| Return On Equity | -0.0915 | ||||
| Return On Asset | 0.0097 |
Accuray Incorporated Leadership Team
Elected by the shareholders, the Accuray Incorporated's board of directors comprises two types of representatives: Accuray Incorporated inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accuray. The board's role is to monitor Accuray Incorporated's management team and ensure that shareholders' interests are well served. Accuray Incorporated's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accuray Incorporated's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xavier Misouard, President Region | ||
| Melanie Gebauer, Vice Resources | ||
| GS Jha, Global Officer | ||
| Jesse Chew, Chief VP | ||
| Sandeep Chalke, Interim Officer | ||
| Nancy Hiller, President Region | ||
| Leonel Peralta, Senior Officer | ||
| Jim Dennison, Quality Regulatory | ||
| John Dunn, Chief President | ||
| Todd Brown, Senior Service | ||
| Joshua Levine, CEO and President and Director | ||
| JeanPhilippe Pignol, Chief VP | ||
| Franco Palomba, Chief VP | ||
| Patrick Spine, Sr Officer | ||
| Melanie Rivers, Chief VP | ||
| Ken Mobeck, VP Relations | ||
| Michael CPA, Principal officer | ||
| Juki Hozumi, President Region | ||
| Suzanne MBA, CEO President | ||
| MD MBA, Senior Officer | ||
| Mu Lee, Senior Development | ||
| Gina Corradetti, Chief VP | ||
| Beth Kaplan, Public Director | ||
| Michael Hoge, Senior Operations | ||
| Roger Cao, President REGION | ||
| Ali Pervaiz, Interim CFO | ||
| Jesse JD, Chief VP |
Accuray Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Accuray Incorporated a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0915 | ||||
| Return On Asset | 0.0097 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 362.74 M | ||||
| Shares Outstanding | 102.83 M | ||||
| Shares Owned By Insiders | 2.52 % | ||||
| Shares Owned By Institutions | 6.00 % | ||||
| Number Of Shares Shorted | 4.5 M | ||||
| Price To Earning | 44.00 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.